NPCE vs RF
Neuropace Inc (NPCE) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
RF (RF) common stock.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
RF does not have a complete income-statement cache yet.
NPCE currently screens at market cap $312.2M. RF currently screens at market cap $0.
Not investment advice. Open the NPCE and RF stock pages for the full models.
Not investment advice.